Cargando…
Mesenchymal stem cells and acellular products attenuate murine induced colitis
BACKGROUND: Mesenchymal stem cells (MSCs) are a well-established immunomodulatory agent which can also promote tissue repair and regeneration. Recent studies have demonstrated MSCs as a novel therapeutic for inflammatory bowel disease (IBD), a chronic idiopathic inflammatory disorder of the gastroin...
Autores principales: | Li, Yan, Altemus, Jessica, Lightner, Amy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706051/ https://www.ncbi.nlm.nih.gov/pubmed/33256827 http://dx.doi.org/10.1186/s13287-020-02025-7 |
Ejemplares similares
-
Adipose tissue‐derived mesenchymal stem cells' acellular product extracellular vesicles as a potential therapy for Crohn's disease
por: Altemus, Jessica, et al.
Publicado: (2022) -
Effect of Crohn's disease mesenteric mesenchymal stem cells and their extracellular vesicles on T‐cell immunosuppressive capacity
por: Dadgar, Neda, et al.
Publicado: (2022) -
A phase IB/IIA study of remestemcel‐L, an allogeneic bone marrow‐derived mesenchymal stem cell product, for the treatment of medically refractory ulcerative colitis: an interim analysis
por: Lightner, Amy L., et al.
Publicado: (2022) -
The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease
por: Driscoll, Julia, et al.
Publicado: (2019) -
Recellularization of Native Tissue Derived Acellular Scaffolds with Mesenchymal Stem Cells
por: Ahmed, Ebtehal, et al.
Publicado: (2021)